DayTwo wins Roche Diabetes Care Innovation Contest
‘DayTwo is perfectly positioned to address unmet patient needs and solve multiple problems through a personalized nutrition solution.’
‘DayTwo is perfectly positioned to address unmet patient needs and solve multiple problems through a personalized nutrition solution.’
Israeli microbiome research will help in predicting, diagnosing and treating a wide range of conditions and diseases.
Israeli pro basketball player Omri Casspi uses DayTwo’s application to maintain sugar levels and adjust his diet according to his activity.
From an oral insulin capsule to a noninvasive glucose monitor, Israeli entrepreneurs and researchers are making life easier for diabetics.
Healthymize, which analyzes chronic disease flare-ups through voice analysis, won the startup contest at the fourth annual mHealth Israel Conference.
Close to $850 million poured into Israeli firms in June 2017 to advance pharma, cybersecurity, e-commerce, autonomous-vehicle and other technologies.
Based on Israeli research on how foods affect individuals’ blood sugar differently, DayTwo kit and app helps plan your optimum personal menu.
Based on Israeli research on how foods affect individuals’ blood sugar differently, DayTwo helps pre-diabetic people plan better menus.